154 related articles for article (PubMed ID: 27975172)
1. Region-Specific Dok2 Overexpression Associates with Poor Prognosis in Human Astrocytoma.
Deshpande RP; Chandra Sekhar YBVK; Panigrahi M; Babu PP
Mol Neurobiol; 2018 Jan; 55(1):402-408. PubMed ID: 27975172
[TBL] [Abstract][Full Text] [Related]
2. SIRP Alpha Protein Downregulates in Human Astrocytoma: Presumptive Involvement of Hsa-miR-520d-5p and Hsa-miR-520d-3p.
Deshpande RP; Chandra Sekhar YBVK; Panigrahi M; Babu PP
Mol Neurobiol; 2017 Dec; 54(10):8162-8169. PubMed ID: 27900675
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinicopathological significance of Nck1 in human astrocytoma progression.
Deshpande RP; Panigrahi M; Y B V K CS; Babu PP
Int J Neurosci; 2019 Feb; 129(2):171-178. PubMed ID: 30146921
[TBL] [Abstract][Full Text] [Related]
4. DOK2 as a marker of poor prognosis of patients with gastric adenocarcinoma after curative resection.
Miyagaki H; Yamasaki M; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Takiguchi S; Fujiwara Y; Mori M; Doki Y
Ann Surg Oncol; 2012 May; 19(5):1560-7. PubMed ID: 22130622
[TBL] [Abstract][Full Text] [Related]
5. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
6. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
7. Elevated expression of HSP10 protein inhibits apoptosis and associates with poor prognosis of astrocytoma.
Fan W; Fan SS; Feng J; Xiao D; Fan S; Luo J
PLoS One; 2017; 12(10):e0185563. PubMed ID: 29028811
[TBL] [Abstract][Full Text] [Related]
8. High ATP2A2 expression correlates with better prognosis of diffuse astrocytic tumor patients.
Li WQ; Zhong NZ; He J; Li YM; Hou LJ; Liu HM; Xia CY; Wang LZ; Lu YC
Oncol Rep; 2017 May; 37(5):2865-2874. PubMed ID: 28339043
[TBL] [Abstract][Full Text] [Related]
9. CDC20 with malignant progression and poor prognosis of astrocytoma revealed by analysis on gene expression.
Ding Y; Yu S; Bao Z; Liu Y; Liang T
J Neurooncol; 2017 May; 133(1):87-95. PubMed ID: 28432586
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of integrin-linked kinase1 overexpression in astrocytoma.
Li J; Zhang H; Wu J; Guan H; Yuan J; Huang Z; Li M
Int J Cancer; 2010 Mar; 126(6):1436-44. PubMed ID: 19676046
[TBL] [Abstract][Full Text] [Related]
11. Gene expression microarray analysis reveals prognostic markers of survival in high grade astrocytomas.
Yang J; Hou Z; Wang C; Wang H; Zhang H
Neurol Res; 2018 Sep; 40(9):744-751. PubMed ID: 29781781
[TBL] [Abstract][Full Text] [Related]
12. SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.
Li L; Li Q; Chen X; Xu M; Li X; Nie L; Chen N; Gong J; Mao Q; Zhou Q
Neuropathology; 2015 Dec; 35(6):510-7. PubMed ID: 26096696
[TBL] [Abstract][Full Text] [Related]
13. The Use of Three Long Non-Coding RNAs as Potential Prognostic Indicators of Astrocytoma.
Zhi F; Wang Q; Xue L; Shao N; Wang R; Deng D; Wang S; Xia X; Yang Y
PLoS One; 2015; 10(8):e0135242. PubMed ID: 26252651
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
15. Native Oligodendrocytes in Astrocytomas Might Inhibit Tumor Proliferation by WIF1 Expression.
Asslaber M; Schauer S; Gogg-Kamerer M; Bernhart E; Quehenberger F; Haybaeck J
J Neuropathol Exp Neurol; 2017 Jan; 76(1):16-26. PubMed ID: 28040794
[TBL] [Abstract][Full Text] [Related]
16. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
17. Tumor Grade versus Expression of Invasion-Related Molecules in Astrocytoma.
Virga J; Bognár L; Hortobágyi T; Zahuczky G; Csősz É; Kalló G; Tóth J; Hutóczki G; Reményi-Puskár J; Steiner L; Klekner A
Pathol Oncol Res; 2018 Jan; 24(1):35-43. PubMed ID: 28161812
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic significance of survivin splice variants in diffusely infiltrating astrocytoma.
Huang Y; Chen X; Chen N; Nie L; Xu M; Zhou Q
J Clin Pathol; 2011 Nov; 64(11):953-9. PubMed ID: 21730264
[TBL] [Abstract][Full Text] [Related]
19. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis.
Sreekanthreddy P; Srinivasan H; Kumar DM; Nijaguna MB; Sridevi S; Vrinda M; Arivazhagan A; Balasubramaniam A; Hegde AS; Chandramouli BA; Santosh V; Rao MR; Kondaiah P; Somasundaram K
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1409-22. PubMed ID: 20530493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]